ArticleWellcome open research2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination: a diagnostic accuracy study.

Alexandra Cann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.